SEC Form 4 · accession 0001652252-17-000048
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald W Hutton
Officer — Vice President and Treasurer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 6, 2017 · 7:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | holding | — | — | — | 2,977 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Sep 5, 2017 | A | 900 | A | — | — | Bio-Rad A Common Stock | 900 | 900 | D |
Explanation of responses
- F1Includes 9.8583, 9.6805 and 7.5328 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/16, 3/31/17 and 6/30/17, respectively.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.